Correlation Between Universal Vision and Sinphar Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Universal Vision and Sinphar Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Universal Vision and Sinphar Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Universal Vision Biotechnology and Sinphar Pharmaceutical Co, you can compare the effects of market volatilities on Universal Vision and Sinphar Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Universal Vision with a short position of Sinphar Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Universal Vision and Sinphar Pharmaceutical.

Diversification Opportunities for Universal Vision and Sinphar Pharmaceutical

0.54

Correlation Coefficient

Universal Vision  Sinphar Pharmaceutical

Very weak diversification

The 3 months correlation between Universal and Sinphar is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Universal Vision Biotechnology and Sinphar Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sinphar Pharmaceutical and Universal Vision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Universal Vision Biotechnology are associated (or correlated) with Sinphar Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sinphar Pharmaceutical has no effect on the direction of Universal Vision i.e., Universal Vision and Sinphar Pharmaceutical go up and down completely randomly.

Pair Corralation between Universal Vision and Sinphar Pharmaceutical

Assuming the 90 days trading horizon Universal Vision Biotechnology is expected to generate 1.71 times more return on investment than Sinphar Pharmaceutical. However, Universal Vision is 1.71 times more volatile than Sinphar Pharmaceutical Co. It trades about 0.08 of its potential returns per unit of risk. Sinphar Pharmaceutical Co is currently generating about 0.04 per unit of risk. If you would invest  21,750  in Universal Vision Biotechnology on November 29, 2024 and sell it today you would earn a total of  1,550  from holding Universal Vision Biotechnology or generate 7.13% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.25%
Values	Daily Returns

Universal Vision Biotechnology  vs.  Sinphar Pharmaceutical Co

Universal Vision Bio

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Universal Vision Biotechnology are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Universal Vision may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Sinphar Pharmaceutical

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Sinphar Pharmaceutical Co are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Sinphar Pharmaceutical is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Universal Vision and Sinphar Pharmaceutical

The main advantage of trading using opposite Universal Vision and Sinphar Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Universal Vision position performs unexpectedly, Sinphar Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinphar Pharmaceutical will offset losses from the drop in Sinphar Pharmaceutical's long position.

The idea behind Universal Vision Biotechnology and Sinphar Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.